Menopausal Hormone Therapy in Gynecologic Cancer Survivors: A Review of the Evidence and Practice Recommendations

Clinical Obstetrics and Gynecology
Ekta KapoorStephanie S Faubion

Abstract

Gynecologic cancers are common in the United States and represent a significant health burden. Treatment of these cancers often causes premature cessation of ovarian function, with resultant symptoms that are often more severe than those associated with natural menopause. Hormone therapy is the most effective treatment for menopausal symptoms, but the decision-making process about its use can be complex for survivors of gynecologic cancer. In this review, we provide evidence-based recommendations about the use of hormone therapy after gynecologic cancer.

References

Jul 1, 1989·International Journal of Radiation Oncology, Biology, Physics·S S IngramM Varia
Nov 1, 1996·American Journal of Obstetrics and Gynecology·J A ChapmanM L Berman
May 4, 2005·Lancet·Valerie BeralUNKNOWN Million Women Study Collaborators
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard R BarakatUNKNOWN Gynecologic Oncology Group Study
Mar 29, 2006·Fertility and Sterility·Lisa GallicchioJodi A Flaws
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A AyhanAtike Sever
Aug 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joanna B MadalinskaNeil K Aaronson
Oct 5, 2006·Journal of the National Cancer Institute·James V LaceyPatricia Hartge
Nov 30, 2006·International Journal of Cancer. Journal International Du Cancer·Amy Berrington de GonzálezUNKNOWN International Collaboration of Epidemiological Studies of Cervical Cancer
Dec 21, 2006·British Journal of Cancer·K N DanforthS E Hankinson
Apr 24, 2007·Menopause International·Joan PitkinJennifer Williamson
May 22, 2007·Lancet·Valerie BeralGillian Reeves
Jun 19, 2007·Human Reproduction Update·Claudia M GreiserMartina Dören
Oct 4, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Naim ShabaniIoannis Mylonas
Jan 29, 2008·Gynecologic Oncology·Bo ZhouBin Wang
Aug 21, 2008·Menopause International·Lynne T ShusterWalter A Rocca
Feb 7, 2009·The New England Journal of Medicine·Lawrence M Nelson
Jun 25, 2009·International Journal of Cancer. Journal International Du Cancer·Stalo KarageorgiImmaculata De Vivo
Jul 16, 2009·JAMA : the Journal of the American Medical Association·Lina Steinrud MørchOjvind Lidegaard
Sep 8, 2009·Maturitas·Lynne T ShusterWalter A Rocca
Dec 19, 2009·Maturitas·Piksi Singh, Martin K Oehler
Oct 4, 2012·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Jonathan S BerekMichael Friedlander
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 2, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Seung-Hyuk ShimSoo-Nyung Kim
Oct 5, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ingvild Løberg TangenHelga B Salvesen
Nov 19, 2014·Menopause : the Journal of the North American Menopause Society·Asa Hallqvist EverhovKarin E Smedby
Jan 4, 2015·Steroids·Susan B Brown, Susan E Hankinson
Feb 17, 2015·Lancet·UNKNOWN Collaborative Group On Epidemiological Studies Of Ovarian CancerR Peto
Apr 8, 2015·Climacteric : the Journal of the International Menopause Society·S S FaubionW A Rocca
Oct 1, 2015·International Journal of Cancer. Journal International Du Cancer·Lina S MørchØjvind Lidegaard
Sep 14, 2016·Maturitas·Carol L KuhleStephanie S Faubion
Jun 27, 2017·Menopause : the Journal of the North American Menopause Society·UNKNOWN The NAMS 2017 Hormone Therapy Position Statement Advisory Panel

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
hysterectomy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

BMJ : British Medical Journal
Helen Roberts
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
James V Lacey
© 2022 Meta ULC. All rights reserved